［1］VANDER HEIDEN MG,DEBERARDINIS RJ.Understanding the intersections between metabolism and cancer biology［J］.Cell,2017,168(4):657-669.
［2］PAVLOVA NN,THOMPSON CB.The emerging hallmarks of cancer metabolism［J］.Cell Metab,2016,23(1):27-47.
［3］KHAN NA,NIKKANEN J,YATSUGA S,et al.mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression［J］.Cell Metab,2017,26(2):419-428.
［4］YE J,FAN J,VENNETI S,et al.Serine catabolism regulates mitochondrial redox control during hypoxia［J］.Cancer Discov,2014,4(12):1406-1417.
［5］ALBERT ML,JIANGBIN Y.The PHGDH enigma:Do cancer cells only need serine or also a redox modulator［J］.Cancer Letters,2020,28(476):97-105.
［6］KRISHNAMOORTHY J,TENKERIAN C,GUPTA J,et al.Downregulation of PERK activity and eIF2α serine 51 phosphorylation by mTOR complex 1 elicits pro-oxidant and pro-death effects in tuberous sclerosis-deficient cells［J］.Cell Death Dis,2018,9(3):254-259.
［7］SVOBODA LK,TEH SSK,SUD S,et al.Menin regulates the serine biosynthetic pathway in Ewing sarcoma［J］.J Pathol,2018,245(3):324-336.
［8］SPIRINA LV,KONDAKOVA IV,YURMAZOV ZA,et al.VHL expression in kidney cancer:Relation to metastasis development,transcription and growth factors and component of Akt/m-TOR signaling pathway［J］.Bull Exp Biol Med,2019,167(5):671-675.
［9］SILVA CL,OLIVAL A,PERESTRELO R,et al.Untargeted urinary 1H NMR-based metabolomic pattern as a potential platform in breast cancer detection［J］.Metabolites,2019,9(11):269-273.
［10］ZHOU Z,LI M,ZHANG L,et al.Oncogenic kinase-induced PKM2 tyrosine 105 phosphorylation converts nononcogenic PKM2 to a tumor promoter and induces cancer stem-like cells［J］.Cancer Res,2018,78(9):2248-2261.
［11］MA C,ZU X,LIU K,et al.Knockdown of pyruvate kinase M inhibits cell growth and migration by reducing NF-κB activity in triple-negative breast cancer cells［J］.Mol Cells,2019,42(9):628-636.
［12］SUZUKI A,PURI S,LELAND P,et al.Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer［J］.PLoS One,2019,14(5):e0217131.
［13］ZHANG M,ZHANG H,HONG H,et al.MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway［J］.Am J Cancer Res,2019,9(4):765-778.
［14］BI YH,HAN WQ,LI RF,et al.Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions［J］.World J Gastroenterol,2019,25(16):1936-1949.
［15］MAO D,REUTER CM,RUZHNIKOV MRZ,et al.De novo EIF2AK1 and EIF2AK2 variants are associated with developmental delay,leukoencephalopathy,and neurologic decompensation［J］.Am J Hum Genet,2020,106(4):570-583.
［16］ALNUQAYDAN AM,RAH B,ALMUTARY AG,et al.Synergistic antitumor effect of 5-fluorouracil and withaferin:A induces endoplasmic reticulum stress-mediated autophagy and apoptosis in colorectal cancer cells［J］.Am J Cancer Res,2020,10(3):799-815.
［17］HONG SE,KIM MR,JANG SK,et al.Hypoxia suppresses cysteine deprivation-induced cell death via ATF4 regulation in MDA-MB-231 breast cancer cells［J］.Anticancer Res,2020,40(3):1387-1394.
［18］MCLAUGHLIN M,PEDERSEN M,ROULSTONE V,et al.The PERK inhibitor GSK2606414 enhances reovirus infection in head and neck squamous cell carcinoma via an ATF4-dependent mechanism［J］.Mol Ther Oncolytics,2020,17(16):238-249.
［19］ISHIDA CT,ZHANG Y,BIANCHETTI E,et al.Metabolic reprogramming by dual AKT/ERK inhibition through imipridones elicits unique vulnerabilities in glioblastoma［J］.Clin Cancer Res,2018,24(21):5392-5406.
［20］BIAｌOPIOTROWICZ E,NOYSZEWSKA-KANIA M,KACHAMAKOVA-TROJANOWSKA N,et al.Serine biosynthesis pathway supports MYC-miR-494-EZH2 feed-forward circuit necessary to maintain metabolic and epigenetic reprogramming of Burkitt lymphoma cells［J］.Cancers,2020,12(3):580-583.
［21］PINWEHA P,RATTANAPORNSOMPONG K,CHAROENSAWAN V,et al.MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers［J］.Comput Struct Biotechnol J,2016,4(14):223-233.
［22］DENICOLA GM,CHEN PH,MULLARKY E,et al.NRF2 regulates serine biosynthesis in non-small cell lung cancer［J］.Nat Genet,2015,47(12):1475-1481.
［23］YOSHINO H,NOHATA N,MIYAMOTO K,et al.PHGDH as a key enzyme for serine biosynthesis in HIF2α-targeting therapy for renal cell carcinoma［J］.Cancer Res,2017,77(22):6321-6329.
［24］SAMANTA D,PARK Y,ANDRABI SA,et al.PHGDH expression is required for mitochondrial redox homeostasis,breast cancer stem cell maintenance,and lung metastasis［J］.Cancer Res,2016,76(15):4430-4442.
［25］DING J,LI T,WANG X,et al.The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation［J］.Cell Metab,2013,18(6):896-907.
［26］AMELIO I,MARKERT EK,RUFINI A,et al.Melinop73 regulates serine biosynthesis in cancer［J］.Oncogene,2014,33(42):5039-5046.
［27］MA L,TAO Y,DURAN A,et al.Control of nutrient stress-induced metabolic reprogramming by PKCζ PKCzeta in tumorigenesis［J］.Cell,2013,152(3):599-611.
［28］JIA XQ,ZHANG S,ZHU HJ,et al.Increased expression of PHGDH and prognostic significance in colorectal cancer［J］.Transl Oncol,2016,9(3):191-196.
［29］SONG ZW,FENG C,LU YL,et al.PHGDH is an independent prognosis marker and contributes cell proliferation,migration and invasion in human pancreatic cancer［J］.Gene,2018,642:43-50.
［30］MA XH,LI BY,LIU J,et al.Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E［J］.J Exp Clin Cancer Res,2019,38(1):66-72.
［31］FAN J,TENG X,LIU L,et al.Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate［J］.ACS Chem Biol,2015,10(2):510-516.
［32］WEINSTABL H,TREU M,RINNENTHAL J,et al.Intracellular trapping of the selective phosphoglycerate dehydrogenase (PHGDH) inhibitor BI-4924 disrupts serine biosynthesis［J］.J Med Chem,2019,62(17):7976-7997.
［33］MURPHY JP,GIACOMANTONIO MA,PAULO JA,et al.The NAD+ salvage pathway supports PHGDH-driven serine biosynthesis［J］.Cell Rep,2018,24(9):2381-2391.
［34］MULLARKY E,XU J,ROBIN AD,et al.Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells［J］.Bioorg Med Chem Lett,2019,29(17):2503-2510.
［35］PACZIA N,BECKER-KETTERN J,CONROTTE JF,et al.3-phosphoglycerate transhydrogenation instead of dehydrogenation alleviates the redox state dependency of yeast de novo l-serine synthesis［J］.Biochemistry,2019,58(4):259-275.